4278638
Last Update Posted: 2020-10-23
Recruiting status is unknown
All Genders accepted | 18 Years + |
120 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
IORT in Local Advanced Laryngocarcinoma
The incidence of laryngeal cancer accounts for about 1 ~ 5% of the total body tumors. For the surgical treatment of laryngeal cancer, the development trend of laryngocarcinoma treatment is to improve the local control rate, preserve the laryngeal function of patients as far as possible, and improve the life quality of patients. The efficacy, safety and feasibility of intraoperative radiotherapy (IORT) in head and neck cancer has been demonstrated in multiple institutional (3-5) studies to optimize local control. It is still unclear whether IORT can improve the local control and have efficacy, safety and feasibility in clinic. The purpose of this study was to observe the efficacy, safety and feasibility of IORT in local advanced laryngocarcinoma .
Eligibility
Relevant conditions:
Laryngeal Neoplasms
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
Xinyuan Gong
gxy0007@163.com
+8613436640313
Data sourced from ClinicalTrials.gov